Skip to main content
Clinical Trials/CTRI/2023/09/057402
CTRI/2023/09/057402
Not yet recruiting
Phase 4

A comparative study of daily low dose and intermittent dose of oral isotretinoin in patients of grade 2 acne vulgaris - NI

orth Eastern Indira Gandhi Regional Institute of Health and Medical Sciences0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: L700- Acne vulgaris
Sponsor
orth Eastern Indira Gandhi Regional Institute of Health and Medical Sciences
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
orth Eastern Indira Gandhi Regional Institute of Health and Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Patients aged 18 years and above and diagnosed with grade 2 acne vulgaris after clinical assessment who are isotretinoin naive and who have not responded to previous topical anti acne agents or oral antibiotics

Exclusion Criteria

  • 1\. Pregnant or lactating women
  • 2\. Deranged liver function
  • 3\. Deranged lipid profile
  • 4\. Concomitant oral antibiotics

Outcomes

Primary Outcomes

Not specified

Similar Trials